? The primary goal of this proposal is to organize a laboratory that can study complex neurobiological problems at levels ranging from the molecular to the behavioral and help translate those finding to clinically relevant treatments for smoking cessation. This Career Development Award would free up time to learn about clinical and translational research and develop collaborations with clinical researchers. The studies proposed therefore involve traditional pharmacological, biochemical, and behavioral experiments, as well as use of transgenic and knock-out technology but will be based on ongoing collaborations with clinical faculty. The career development plan involves attendance at seminars addressing translational research and hands on work with faculty members whose expertise is in human studies of smoking and smoking cessation. Finally, this proposal will allow time for attendance at meetings on transdisciplinary research on tobacco abuse, as well as the time to assist with experiments in laboratories focusing on clinical issues related to smoking cessation.
The Specific Aims of this project are to provide a basic science background for the behavioral, neurochemical and molecular events underlying nicotine addiction and to design these studies so that findings can be translated into human studies and ultimately into new therapeutics for smoking cessation.
These Aims will be achieved using wild-type mice, traditional knock-out mice that lack expression of the beta 2 subunit of the neuronal nicotinic receptor throughout development in all tissues, and mice that conditionally express this subunit only in particular brain areas under the control of the tetracycline-regulated promoter. Together these different approaches will build a bridge between molecular biological data on nicotinic receptor subtypes, the large body of behavioral pharmacological literature on the actions of nicotine in vivo, and human studies on the physiological and behavioral effects of smoking. ? ? ? ?

Agency
National Institute of Health (NIH)
Institute
National Institute on Drug Abuse (NIDA)
Type
Research Scientist Development Award - Research (K02)
Project #
5K02DA000436-10
Application #
7479689
Study Section
Human Development Research Subcommittee (NIDA)
Program Officer
Aigner, Thomas G
Project Start
1999-09-05
Project End
2009-07-31
Budget Start
2008-08-01
Budget End
2009-07-31
Support Year
10
Fiscal Year
2008
Total Cost
$125,388
Indirect Cost
Name
Yale University
Department
Psychiatry
Type
Schools of Medicine
DUNS #
043207562
City
New Haven
State
CT
Country
United States
Zip Code
06520
Park, Aesoon; O'Malley, Stephanie S; King, Sarah L et al. (2014) Mediating role of stress reactivity in the effects of prenatal tobacco exposure on childhood mental health outcomes. Nicotine Tob Res 16:174-85
Jung, Yonwoo; Mulholland, Patrick J; Wiseman, Shari L et al. (2013) Constitutive knockout of the membrane cytoskeleton protein beta adducin decreases mushroom spine density in the nucleus accumbens but does not prevent spine remodeling in response to cocaine. Eur J Neurosci 37:1-9
Guez-Barber, Danielle; Fanous, Sanya; Harvey, Brandon K et al. (2012) FACS purification of immunolabeled cell types from adult rat brain. J Neurosci Methods 203:10-8
Horst, Nicole K; Heath, Christopher J; Neugebauer, Nichole M et al. (2012) Impaired auditory discrimination learning following perinatal nicotine exposure or ?2 nicotinic acetylcholine receptor subunit deletion. Behav Brain Res 231:170-80
Neugebauer, Nichole M; Henehan, Robert M; Hales, Claire A et al. (2011) Mice lacking the galanin gene show decreased sensitivity to nicotine conditioned place preference. Pharmacol Biochem Behav 98:87-93
Weinberger, Andrea H; McKee, Sherry A; Picciotto, Marina R et al. (2011) Examining antidepressant drug response by smoking status: why is it important and how often is it done? J Psychopharmacol 25:1269-76
Mineur, Yann S; Abizaid, Alfonso; Rao, Yan et al. (2011) Nicotine decreases food intake through activation of POMC neurons. Science 332:1330-2
Mineur, Yann S; Einstein, Emily B; Seymour, Patricia A et al. (2011) ?4?2 nicotinic acetylcholine receptor partial agonists with low intrinsic efficacy have antidepressant-like properties. Behav Pharmacol 22:291-9
Mineur, Yann S; Picciotto, Marina R (2010) Nicotine receptors and depression: revisiting and revising the cholinergic hypothesis. Trends Pharmacol Sci 31:580-6
Heath, Christopher J; King, Sarah L; Gotti, Cecilia et al. (2010) Cortico-thalamic connectivity is vulnerable to nicotine exposure during early postnatal development through ?4/?2/?5 nicotinic acetylcholine receptors. Neuropsychopharmacology 35:2324-38

Showing the most recent 10 out of 48 publications